U.S. Durable Medical Equipment Industry Overview The U.S. durable medical equipment market size is expected to reach USD 92.8 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.7% from 2022 to 2030. The rising prevalence of chronic diseases and increasing penetration of home healthcare services and staff are the key factors driving the product demand. The demand for durable medical equipment (DME) is projected to witness a rise during the forecast period due to high adoption. The COVID-19 pandemic has disrupted the transportation and supply chain of the durable medical equipment market due to the restrictions imposed by the government. As the demand for the equipment increases for medical purposes to fight against COVID-19, the supply of the product also increases. COVID-19 led to an increase in the demand for medical beds and therapeutic mattresses, and volumes were also high within the U.S. rental operations. U.S. Durable Medical Equipment Market Segmentation Grand View Research has segmented the U.S. durable medical equipment market report based on product: Based on the Product Insights, the market is segmented into personal mobility devices, bathroom safety devices & medical furniture and monitoring & therapeutic devices
Key Companies Profile & Market Share Insights The key companies are continuously focusing on initiatives such as mergers & acquisitions, regional expansion, and novel product development. The market players are introducing innovative technologies and products to expand their product portfolio to capture a large share in the market. The market consists of big players as well as local distributors and suppliers. The key players are focusing on providing cost-efficient products, which can be used remotely. Some prominent players in the U.S. durable medical equipment include:
Market Industry Development
Order a free sample PDF of the U.S. Durable Medical Equipment Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
0 Comments
U.S. Home Infusion Therapy Industry Overview The U.S. home infusion therapy market size is expected to reach USD 31.7 billion by 2030, registering a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The growing geriatric population and increasing prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, infections, dehydration, and nausea & vomiting are majorly driving the growth of the market. Factors such as the increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth. Growing cases of Hospital Acquired Infections (HAI) are also driving the growth of the market for home infusion therapy in the U.S. According to the U.S. Centers for Disease Control and Prevention (CDC), annually, approximately 1.7 million admitted patients are affected by Healthcare Acquired infections (HCAI) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially. U.S. Home Infusion Therapy Market Segmentation Grand View Research has segmented the U.S. home infusion therapy market report based on product and application: Based on the Product Insights, the market is segmented into infusion pumps, intravenous sets, IV cannulas and needleless connectors
Based on the Application Insights, the market is segmented into anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals and others
Key Companies Profile & Market Share Insights The players operating in the market for home infusion therapy in the U.S. are focusing on adopting growth strategies, such as mergers and acquisitions, new product launches, innovations in the existing technologies, and more. Some prominent players in the U.S. home infusion therapy market include:
Market Industry Development
Order a free sample PDF of the U.S. Home Infusion Therapy Market Intelligence Study, published by Grand View Research. Next-Generation Sequencing Services Industry Overview The global next-generation sequencing services market size is expected to reach USD 4.55 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 18.3% from 2022 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users. Next-Generation Sequencing Services Market Segmentation Grand View Research has segmented the global next-generation sequencing services market report on the basis of service type, workflow, end-use, and region: Based on the Service Type Insights, the market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services
Based on the Workflow Insights, the market is segmented into pre-sequencing, sequencing and data analysis
Based on the End-use Insights, the market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities and others
Next-Generation Sequencing Services Regional Outlook
Key Companies Profile & Market Share Insights Key participants have collaborated with several platform manufacturers to receive a license for the use of NGS at their centers. Furthermore, manufacturers are undertaking various marketing strategies to capitalize on avenues in untapped markets such as India, Brazil, and China. Some prominent players in the global next-generation sequencing services market include:
Market Industry Development
Order a free sample PDF of the Next-Generation Sequencing Services Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter Real-time PCR, Digital PCR, And End-point PCR Industry Overview The global real-time PCR, digital PCR, and end-point PCR market size are expected to reach USD 14.63 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to decline at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2022 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years. Real-time PCR, Digital PCR, And End-point PCR Market Segmentation Grand View Research has segmented the global real-time PCR, digital PCR, and end-point PCR market report based on technology, product, application, and region: Based on the Technology Insights, the market is segmented into quantitative, digital and end-point
Based on the Product Insights, the market is segmented into consumables & reagents, instruments and software & services
Based on the Application Insights, the market is segmented into clinical, research and forensic
Real-time PCR, Digital PCR, And End-point PCR Regional Outlook
Key Companies Profile & Market Share Insights Major market players are adopting marketing strategies such as geographical expansion, partnerships, strategic collaborations, and mergers and acquisitions in emerging and economically favorable regions. Some prominent players in the global real-time PCR, digital PCR, and end-point PCR market include:
Market Industry Development
Order a free sample PDF of the Real-time PCR, Digital PCR, And End-point PCR Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Clinical Trial Imaging Industry Overview The global clinical trial imaging market is expected to reach USD 1.97 billion by 2030, exhibiting a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker. Clinical Trial Imaging Market Segmentation Grand View Research has segmented the global clinical trial imaging market on the basis of service, application, end-use, and region: Based on the Service Insights, the market is segmented into clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services and project and data management
Based on the Application Insights, the market is segmented into NASH, CKD, diabetes, cardiovascular diseases and others
Based on the End-use Insights, the market is segmented into biotechnology and pharmaceutical companies, medical devices manufacturers, academic and government research institutes, CROs and others
Clinical Trial Imaging Regional Outlook
Key Companies Profile & Market Share Insights Some of the key players in this market are Parexel International Corporation, Intrinsic Imaging, Bioclinica, and ICON plc. These market players are focusing on growth strategies such as mergers & acquisitions as well as signing contracts. Some of the prominent players in the global clinical trial imaging market include:
Market Industry Development
Order a free sample PDF of the Clinical Trial Imaging Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter Surgical Instruments Tracking Systems Industry Overview
The global surgical instruments tracking systems market size is anticipated to reach USD 513.09 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 12.1% over the forecast period. The increasing need for inventory management and implementation of Unique Device Identification (UDI) regulations formed by the FDA are some of the major factors supporting the market growth. Furthermore, surgical tool manufacturers are expected to track their products from manufacturing to distribution. The goal of device tracking is to ensure that instrument manufacturers set up mechanisms that allow them to quickly locate devices in commercial distribution. The proposed UDI regulations by the U.S. Food & Drug Administration (FDA) are projected to propel market growth. Surgical Instruments Tracking Systems Market Segmentation Grand View Research has segmented the global surgical instruments tracking systems market report based on product, technology, end use, and region: Based on the Product Insights, the market is segmented into hardware, software and services
Based on the Technology Insights, the market is segmented into barcodes and RFID
Based on the End-use Insights, the market is segmented into hospitals and others
Key Companies Profile & Market Share Insights The leading companies are undertaking several strategic initiatives, such as product developments or launches, collaborations, and mergers & acquisitions along with regional expansions for gaining a higher market share. Some of the prominent players in the global surgical instruments tracking systems market include:
Market Industry Development
Order a free sample PDF of the Surgical Instruments Tracking Systems Market Intelligence Study, published by Grand View Research. Gene Therapy Industry Overview The global gene therapy market size was valued at USD 2.26 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 20-.4% from 2021 to 2028. The expanding arena of advanced therapies and gene delivery technologies has created an increasingly competitive dynamic where a substantial number of market players are engaged in the commercialization of their gene therapy products. Therapy developers are investing in collaboration/mergers and acquisition deals as a viable strategy to enhance in-house expertise and strengthen product pipelines. These factors are expected to boost the market growth. Although the high prices of currently available therapies incentivize therapy development, it limits accessibility and can result in market withdrawals due to the lack of economic viability of the products. Gather more insights about the market drivers, restrains and growth of the Global Gene Therapy Market Thus, several payment models, such as financial-based agreements and health outcomes-based agreements, have been introduced or suggested to increase the accessibility and market survival of therapies. These models have significantly impacted the adoption of therapies in the market. Currently, the world is trying to mitigate the adverse impact of the SARS-CoV-2 pandemic to restore the revenue flow in markets. The cell and gene therapy sector has been impacted to a considerable extent. Since many universities have shut down and halted all non-essential research & enrollment processes for clinical trials, progress in the ongoing R&D has been slow. However, several initiatives have been undertaken by biopharma companies to gain a competitive edge in the market. Companies are adopting various market entry strategies, such as biopharma facility expansions, collaborations with other key stakeholders, and development with Contract Manufacturing Organizations (CMOs). For instance, in March 2020, Univercells launched Exothera, a viral vector CDMO that serves cell and gene therapy developers. The delay in commercialization of Zynteglo due to the pandemic has impeded the market growth to a considerable extent. On the other hand, in July 2020, Novartis received the EMA approval for its two European sites for commercial manufacturing of CAR-T therapies. Furthermore, Kite, a Gilead Company, received the U.S. FDA approval for its Tecartus, a CAR T treatment for patients with relapsed or refractory mantle cell lymphoma. These approvals depict the continued momentum of the new area of medicine in this segment. Browse through Grand View Research's Biotechnology Industry Research Reports.
Gene Therapy Market Segmentation Grand View Research has segmented the global gene therapy market on the basis of indication, vector type, and region: Gene Therapy Indication Outlook (Revenue, USD Million, 2017 - 2028)
Market Share Insights
Key Companies profiled: Some prominent players in the global gene therapy market include
Order a free sample PDF of the Gene Therapy Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Hearing Aids Industry Overview The global hearing aids market size was valued at USD 10.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030. The market growth can be attributed to key factors such as the increasing adoption of hearing aids devices, growing awareness regarding technologically advanced devices for the treatment of deafness and hearing impairment, and the increasing prevalence of hearing loss due to the growing geriatric population. The market is a highly technological driven market that has seen the emergence of novel products including smart linked hearing aids, invisible hearing aids, and AI- and Bluetooth-enabled hearing aids that can be connected to Android or iOS. For example, in August 2021, Phonak introduced the world's first waterproof rechargeable, Audéo Life hearing aid. Hence, hearing aid companies are improving patients' experiences with new features and technology, which is expected to fuel market growth in the coming years. Moreover, in the U.S., approximately 15% of patients aged between 18 and over suffer from hearing loss. For instance, the FDA announced a proposal in October 2021 that it wants to establish a new category of low-cost over-the-counter hearing aids. Gather more insights about the market drivers, restrains and growth of the Global Hearing Aids Market This opens up a new revenue stream for businesses looking to acquire a foothold in the OTC hearing aid market. Such substantial government and regulatory support are projected to have a long-term positive impact on the hearing aids sector in the U.S. Moreover, hearing service offices and general healthcare service associations of local governments in both developed and developing economies are emphasizing early screening of deafness and the provision of hearing aids to people. As the healthcare sector in emerging economies is moving towards privatization, healthcare infrastructure in these countries is undergoing rapid development. Education and increased awareness regarding health among people are also playing an important role in increasing the demand for these devices and their diagnostic services. The COVID-19 outbreak has had a significant impact on the healthcare industry. Among COVID-19 positive patients, most hospitals are running out of beds. In addition, a number of elective procedures are being canceled or postponed in order to reallocate resources. According to the Hearing Industries Association (HIA), hearing aid sales in the U.S. has declined by 29.7% in the first half of 2020. Due to the postponement of procedures like the cochlear implantation technique, which is one of the most significant treatments to address hearing impairments, the pandemic had a detrimental influence on the total sales of hearing aid support goods. As a result, sales of hearing aids from major manufacturers have decreased. Despite all of these obstacles, the hearing aids business and other medical industries are progressively regaining ground as the COVID-19 situation throughout the world normalizes. Furthermore, countries all over the world are now focused on reducing deafness and this, in turn, has led to the introduction of various initiatives that aim to promote awareness and provide free care to patients. Subsidies, grants, and funding are offered by governments all across the world to prevent and manage hearing disorders. For instance, the New South Wales (NSW) Statewide Infant Screening-Hearing (SWISH) program in Australia aims at identifying babies born with permanent bilateral deafness in NSW. Such initiatives are expected to further boost the demand for these devices globally. The Virto P Black is an integrated in-the-ear hearing device that looks similar to a modern earbud and the ultra-discreet Virto P-Titanium customized titanium hearing aid is also included in this package. Virto Paradise hearing aids, which are enabled by the PRISM sound processing processor, provide unrivaled sound quality and are specifically designed for each person's ears, providing a fully unique hearing experience. Browse through Grand View Research's Medical Devices Industry Research Reports.
Hearing Aids Market Segmentation Grand View Research has segmented the global hearing aids market on the basis of product type, technology type, sales channel, and region: Hearing Aids Product Type Outlook (Volume, ’000 Units; Revenue, USD Million, 2017 - 2030)
Market Share Insights
Key Companies profiled: Some prominent players in the global hearing aids market include
Order a free sample PDF of the Hearing Aids Market Intelligence Study, published by Grand View Research. Nuclear Medicine Industry Overview The global nuclear medicine market size was estimated at USD 8.1 billion in 2021 and is expected to expand at a compound annual growth rate of (CAGR) 13.0% from 2022 to 2030. The market is witnessing growth due to the presence of a robust product pipeline and favorable government initiatives to improve access to nuclear medicine. Currently, betalutin, omburtamab, yttrium-90 microspheres, PNT2003, 177Lu-PNT2002, are some of the products under clinical trials. The nuclear medicine market has been moderately impacted due to SARS-CoV-2. The operation of reactors has been largely classified as an essential service, given its criticality. Therefore, nuclear reactors were not shut down during the SARS-CoV-2 lockdown. For instance, under Section 71 of the Labour Act 66 of 1995 in South Africa, its SAFARI-1 reactor remained operational during the lockdown enforced in the country post-March 2020. Gather more insights about the market drivers, restrains and growth of the Global Nuclear Medicine Market Moreover, in an article published by ANSTO in May 2020, it was reported that since its reactor provides critical medicines, it had maintained its operations during the COVID-19 crisis, with its staff returning to campus and following strict social distancing measures. According to the American Cancer Society, the estimated incidence of prostate cancer is 268,490, and around 34,500 deaths in 2022 in the U.S. In addition, around 6 out of 10 patients diagnosed are men aged 65 years and older, with a rare incidence in men under 40 years. Recently, in March 2022, the U.S. FDA approved Pluvicto (177Lu-PSMA-617) for the treatment of adults with metastatic prostate cancer. This approval is anticipated to drive market growth. The presence of a favorable reimbursement scenario for radiopharmaceuticals in the U.S. is anticipated to boost market growth. In 2020, the Center for Medical Services (CMS) offered a USD 10 add-on payment for Tc-99m derived from non-highly enriched uranium (HEU) for hospital outpatient service in addition to payment for imaging procedures. The initiatives, in turn, led to greater patient access to much-needed diagnostic nuclear medicines used for life-threatening diseases. Increasing advancements in the diagnosis and treatment of diseases, and approval of new nuclear-medicine-based devices help in addressing patients' treatment needs. For instance, in September 2021, GE Healthcare announced the launch of a novel scanner with a new automated workflow feature that offers an exceptional view of cardiac anatomy and pathology to help physicians to decide the right treatment for a patient. Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
Nuclear Medicine Market Segmentation Grand View Research has segmented the global nuclear medicine market based on product type, application, and region: Nuclear Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)
Market Share Insights
Key Companies profiled: Some prominent players in the global nuclear medicine market include
Order a free sample PDF of the Nuclear Medicine Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Primary Cell Culture Industry Overview The global primary cell culture market size was valued at USD 3.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.6% from 2021 to 2028. The market growth can be primarily attributed to the increasing prevalence of chronic conditions, such as cancer, infections, autoimmune diseases, diabetes mellitus, cardiovascular diseases, and nephrological diseases. This has led to an increase in research, facilitating the high adoption of primary cell cultures. According to the American Cancer Society, there are an estimated 16.9 million cancer patients/survivors in 2020. According to the WHO (2020), 71.0 million people worldwide are suffering from chronic hepatitis C infection. Hence, the rising number of chronic disorders being diagnosed is driving the demand for research on advanced therapies, which is expected to boost the market growth in the coming years. Gather more insights about the market drivers, restrains and growth of the Global Primary Cell Culture Market In addition, the rising usage of primary cell cultures for in-vitro testing and drug screening can be further attributed to the growth of the market for primary cell culture. These are derived from tissues, which facilitates researchers to study cellular structure in the in vivo state, showcasing their normal functioning. As a result, they are used as model systems to study cell biochemistry and physiology, aging processes, signaling studies, and metabolic processes, as well as the effect of toxic compounds and drugs. COVID-19 pandemic is acting as a positive catalyst for the growth of the market for primary cell culture. Researchers are increasingly using primary cell culture for understanding the infection. Standardized and characterized epithelium cell culture models are facilitating the understanding of the physical barrier destroyed by the coronavirus. These models can help mimic the functions and properties of the respiratory tract, leading to a breakthrough for a research outcome turning into a medical application. Moreover, the primary immune cell culture has been proven to be very beneficial in the study of immune repertoire to produce antibodies and antigens for the COVID-19 virus. As per the findings by the scientists from the German Primate Center in Gottingen, the COVID-19 virus could block the infection in lung cells with TMPRSS2, an inhibitor for serine protease. The results have been validated with the experiment using primary cell culture. Browse through Grand View Research's Biotechnology Industry Research Reports.
Primary Cell Culture Market Segmentation Grand View Research has segmented the global primary cell culture market based on product, separation methods, cell type, application, and region: Primary Cell Culture Product Outlook (Revenue, USD Million, 2017 - 2028)
Market Share Insights
Key Companies profiled: Some prominent players in the global primary cell culture market include
Order a free sample PDF of the Primary Cell Culture Market Intelligence Study, published by Grand View Research. |
Archives
December 2023
Categories |